Skip to main content
Fig. 7 | Journal of Experimental & Clinical Cancer Research

Fig. 7

From: Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression

Fig. 7

Analysis of clinical data indicates the potential diagnostic role of miR-218-5p in colorectal cancer. A–C Comparison of miR-218-5p, PTPRR expression, and Parvimonas micra abundance in cancer mucosa (C) and adjacent normal tissues (N). D–E Correlation analysis between P. micra abundance and miR-218-5p or miR-218-5p and PTPRR expression. F Survival rates of high- and low-expressing miR-218-5p in stage T4 samples from the TCGA data. G Expression of miR-218-5p in stages T1–T4 in the TCGA data. H Expression of miR-218-5p in pathological stages I–IV in the TCGA data. I ROC curve for the diagnosis of colorectal cancer based on miR-218-5p

Back to article page